50 related articles for article (PubMed ID: 21338318)
1. Clinical significance of tumor protein D52 immunostaining in a large series of Ewing's sarcoma family of tumors.
Machado I; López-Guerrero JA; Calabuig-Fariñas S; Hardy JR; Scotlandi K; Picci P; Byrne JA; Llombart-Bosch A
Pediatr Dev Pathol; 2011; 14(3):255-6. PubMed ID: 21338318
[No Abstract] [Full Text] [Related]
2. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
[TBL] [Abstract][Full Text] [Related]
4. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
[TBL] [Abstract][Full Text] [Related]
5. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
[TBL] [Abstract][Full Text] [Related]
6. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
Abudu A; Mangham DC; Reynolds GM; Pynsent PB; Tillman RM; Carter SR; Grimer RJ
Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
[TBL] [Abstract][Full Text] [Related]
8. PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour.
Kang GH; Kim KM; Park CK; Kang DY
Histopathology; 2009 Sep; 55(3):368-9. PubMed ID: 19723158
[No Abstract] [Full Text] [Related]
9. Intramyofiber skeletal muscle invasion in Ewing's sarcoma of bone: clinicopathologic observations from the intergroup Ewing's sarcoma study.
Stratton B; Askin FB; Kissane JM
Am J Pediatr Hematol Oncol; 1982; 4(2):231-5. PubMed ID: 7114406
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of P53 status in Ewing sarcoma.
de Alava E; Antonescu CR; Panizo A; Leung D; Meyers PA; Huvos AG; Pardo-Mindán FJ; Healey JH; Ladanyi M
Cancer; 2000 Aug; 89(4):783-92. PubMed ID: 10951341
[TBL] [Abstract][Full Text] [Related]
11. Ewing's sarcoma: value of tumor necrosis as a predictive factor.
de Stéfani E; Carzoglio J; Deneo Pellegrini H; Olivera L; Cendan M; Kasdorf H
Bull Cancer; 1984; 71(1):16-21. PubMed ID: 6713111
[TBL] [Abstract][Full Text] [Related]
12. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
Navarro S; Giraudo P; Karseladze AI; Smirnov A; Petrovichev N; Savelov N; Alvarado-Cabrero I; Llombart-Bosch A
Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
15. [Cytologic and cytochemical characteristics of Ewing's tumor and reticulosarcoma of the bone].
Esiutina OS
Lab Delo; 1972; 4():218-21. PubMed ID: 4119842
[No Abstract] [Full Text] [Related]
16. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
17. [Cooperative Ewing's Sarcoma Studies 81/86: pathologico-anatomic and immunohistochemical findings and differential diagnosis of Ewing sarcoma].
Schmidt D; Harms D
Klin Padiatr; 1988; 200(3):236-42. PubMed ID: 3062261
[TBL] [Abstract][Full Text] [Related]
18. Assessment of muscarinic and nicotinic acetylcholine receptor expression in primitive neuroectodermal tumor/ewing family of tumor and desmoplastic small round cell tumor: an immunohistochemical and Western blot study of tissue microarray and cell lines.
Schlauder SM; Steffensen TS; Morgan M; Letson DG; Pledger WJ; Ma L; Bui MM
Fetal Pediatr Pathol; 2008; 27(2):83-97. PubMed ID: 18568996
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Lee JA; Kim DH; Cho J; Lim JS; Koh JS; Yoo JY; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
Jpn J Clin Oncol; 2011 Jun; 41(6):776-82. PubMed ID: 21415003
[TBL] [Abstract][Full Text] [Related]
20. [Biological markers of diagnostic value in Ewing's sarcoma: the use of antibodies against the antigen p30/32 MIC2, called 013].
Ladenheim H; García A; Avagnina A; Porta J; Elsner B
Medicina (B Aires); 1995; 55(2):184-6. PubMed ID: 7565061
[No Abstract] [Full Text] [Related]
[Next] [New Search]